MET METLIFE INC
Life Insurance · NYSE · SEC CIK 1099219 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY14.8%
TTM net income YoY33.5%
TTM EPS YoY44.1%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR26.2%
Margins
Gross margin—
Operating margin8.2%
Net margin6.2%
FCF margin—
EBITDA margin8.3%
Returns
ROE20.0%
ROA0.7%
ROIC (approx.)93.8%
Asset turnover0.11x
Leverage & solvency
Liabilities / assets96.9%
Debt / equity0.00x
Current ratio—
Interest coverage8.71x
Cash quality & payout
Operating cash flow / net income2.73x
Accruals ratio-1.2%
Payout ratio29.4%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $77.08B | $70.99B | $66.91B | $68.77B | $68.70B |
| SG&A expense | $560.00M | $481.00M | $828.00M | $669.00M | $670.00M |
| Operating income | $6.14B | $6.00B | $5.72B | $5.98B | — |
| Interest expense | $724.00M | $738.00M | $740.00M | $655.00M | $647.00M |
| Pretax income | $4.66B | $5.62B | $2.16B | $6.36B | $8.52B |
| Income tax | $1.26B | $1.18B | $560.00M | $1.06B | $1.64B |
| Net income | $3.38B | $4.43B | $1.58B | $5.28B | $6.86B |
| EBITDA | $6.25B | $6.12B | $5.83B | $6.10B | — |
| EPS (basic) | 4.74 | 5.98 | 1.82 | 6.35 | 7.71 |
| EPS (diluted) | 4.71 | 5.94 | 1.81 | 6.30 | 7.65 |
| Dividends declared per share | 2.25 | 2.15 | 2.06 | 1.98 | 1.90 |
| Weighted avg. shares (diluted) | 673.30M | 711.10M | 762.30M | 808.90M | 869.40M |
| Banking | |||||
| Loans, net | — | — | — | $83.76B | $79.23B |
| Balance sheet | |||||
| Cash & equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B |
| Short-term investments | $3.60B | $5.16B | $6.04B | $4.93B | $7.18B |
| Goodwill | $9.61B | $8.90B | $9.24B | $9.30B | $9.54B |
| Intangibles | $636.00M | $710.00M | $794.00M | $876.00M | $972.00M |
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B |
| Short-term debt | $355.00M | $465.00M | $119.00M | $175.00M | $341.00M |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B |
| Shareholders' equity | $28.40B | $27.45B | $30.02B | $29.88B | $67.48B |
| Shares outstanding | 655.33M | 689.21M | 730.82M | 779.10M | 825.54M |
| Cash flow statement | |||||
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B |
| Investing cash flow | -$15.61B | -$11.49B | -$10.25B | -$2.62B | -$11.19B |
| Financing cash flow | $163.00M | -$3.13B | -$2.94B | -$9.95B | -$1.13B |
| Depreciation & amortization | $117.00M | $124.00M | $112.00M | $118.00M | $123.00M |
| Stock-based compensation | $131.00M | $168.00M | $171.00M | $184.00M | $173.00M |
| Dividends paid | $1.51B | $1.53B | $1.57B | $1.60B | $1.65B |
| Share buybacks | $2.88B | $3.21B | $3.10B | $3.33B | $4.30B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.